Abstract:Fracture risk is increased in type 1 diabetes (T1D). Diabetic neuropathy might contribute to this increased risk directly through effects on bone turnover and indirectly through effects on balance, muscle strength, and gait. We compared patients with T1D with (T1DN+, n = 20) and without (T1DN−, n = 20) distal symmetric sensorimotor polyneuropathy and controls (n = 20). We assessed areal bone mineral density (aBMD) and appendicular muscle mass by dual‐energy X‐ray absorptiometry, microarchitecture by high‐resolution peripheral quantitative tomography at the standard ultra‐distal site and at an exploratory 14% bone length site at the tibia and radius, bone turnover markers, and muscle strength, gait, and balance by Short Physical Performance Battery (SPPB). At the standard ultra‐distal site, tibial cortical porosity was 56% higher in T1DN+ compared with T1DN− (p = .009) and correlated positively with the severity of neuropathy (Toronto Clinical Neuropathy Score; r = 0.347, p = .028) and negatively with nerve conduction amplitude and velocity (r = −0.386, p = .015 and r = −0.358, p = .025, respectively). Similar negative correlations were also observed at the radius (r = −0.484, p = .006 and r = −0.446, p = .012, respectively). At the exploratory 14% offset site (less distal), we found higher trabecular volumetric BMD (tibia 25%, p = .024; radius 46%, p = .017), trabecular bone volume (tibia 25%, p = .023; radius 46%, p = .017), and trabecular number (tibia 22%, p = .014; radius 30%, p = .010) in T1DN– compared with controls. Both CTX and PINP were lower in participants with TD1 compared with controls. No difference was found in aBMD and appendicular muscle mass. T1DN+ had worse performance in the SPPB compared with T1DN– and control. In summary, neuropathy was associated with cortical porosity and worse performance in physical tests. Our findings suggest that bone structure does not fully explain the rate of fractures in T1D. We conclude that the increase in the risk of fractures in T1D is multifactorial with both skeletal and non‐skeletal contributions. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Characteristics of bone metabolism in the male patients with diabetic neuropathy

Changes of bone metabolic biochemical markers and bone mineral density in male patients with type 2 diabetes

The Effects of Type 1 Diabetes and Diabetic Peripheral Neuropathy on the Musculoskeletal System: A Case–Control Study

Bone mineral density and bone metabolic index in patient with type 2 diabetes mellitus complicated by abnormal bone metabolism

Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus

Trabecular and cortical bone microarchitecture using high-resolution peripheral quantitative computed tomographic imaging in diabetic peripheral neuropathy

Bone Health in Patients With Type 2 Diabetes

A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment

Analysis of factors associated with osteopenia and osteoporosis in hospitalized type 2 diabetes mellitus patients

Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions

Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence

Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus

Association Between Bone Mineral Density and Type 2 Diabetes Mellitus: a Meta-Analysis of Observational Studies

BMD and bone metabolism change in elderly males with type 2 diabetes mellitus and diabetic nephropathy

Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus

Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes

Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes

Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus

Correlation between bone mineral density and type 2 diabetes mellitus in elderly men and postmenopausal women

Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients

The paradox of bone mineral density and fracture risk in type 2 diabetes